5 Leading Presentations from the 7th Annual World Stem Cells & Regenerative Medicine Congress



With the buzz growing for the 8th Annual World Stem Cells & Regenerative Medicine Congress later this month, we wanted to take a look back at some of the leading presentations, debates and discussions that took place at last year's event.



This eBook contains 5 of the leading presentations from last year's congress that cover:

  • Lessons learned and challenges to overcome during stem cell therapy clinical trials
  • How to get a stem cell therapy approved and on the market
  • Translating clinical cell therapies into commercialised products

Download the eBook here

In the following pages, you will be able to download the presentations from:

  • Gil Van Bokkelen, President & CEO, Athersys
  • Geoff MacKay, CEO, Organogenesis
  • Eduardo Bravo, CEO, Tigenix
  • Richard Garr, CEO, NeuralStem
  • Donna Skerrett, CMO, Mesoblast

Download the eBook here

The World Stem Cells & Regenerative Medicine Congress Europe in London on the 21st -23rd May 2013, brings together the late stage cell therapy developers, key opinion leaders, senior regenerative medicine stakeholders and the most innovative stem cell researchers to share expertise and discuss what it takes to achieve successful clinical development and commercialise to scale. Here are some of the hot industry topics in place to be debated at this years meeting:

  • Discover the future roadmap for the commercialisation of stem cell-based therapies
  • Discover how to identify your therapy's future manufacturing challenges and create a flexible, scalable and economic commercialisation program
  • Learn how to identify and exploit alternative methods of funding
  • Understand the reimbursement landscape through early dialogue. Use health economics to discover the true value & market penetration of your cell therapy
  • Find out how to streamline clinical development, accelerate approval and minimise lag between approval and reimbursement coverage
  • Understand what partnering in the industry actually looks like and what factors make an attractive acquisition for a larger organisation
  • Uncover the therapeutic potential of iPS cells and discover cutting edge applications of stem cells in drug discovery

Limited places are available, so register before 3rd May 2013 and save £100.

Comments 2

Leave a Reply

Your email address will not be published. Required fields are marked *